1. BARRIERS AND FACILITATORS TO UNDERGOING HEPATITIS C VIRUS (HCV) TESTING THROUGH DRUG TREATMENT PROGRAMS.
- Author
-
Strauss, Shiela M., Munoz-Plaza, Corrine, Tiburcio, Nelson Jose, Astone-Twerell, Janetta, Des Jarlais, Don C., Gwadz, Marya, Hagan, Holly, Osborne, Andrew, and Rosenblum, Andrew
- Subjects
- *
HEPATITIS C diagnosis , *DRUG therapy , *HYPODERMIC needles , *PREVENTIVE health services , *SEXUALLY transmitted disease treatment - Abstract
Given the high prevalence of hepatitis C virus (HCV) infection among drug users, HCV testing is critical in this population. While many drug treatment programs offer HCV testing, patients often do not utilize this essential program-facilitated service. Summarizing data collected in semi-structured interviews and surveys with patients in 25 programs, this paper identifies barriers and facilitators to being tested for HCV through the program. Barriers include the patient's belief that she/he is not HCV infected, fear of needles, fear of obtaining a positive HCV test result, fear of disclosure of such a result, and fear of inappropriate or disrespectful treatment during the testing process. In addition, 38% of HCV sero-unaware or sero-negative patients completing the survey did not know that HCV testing was offered through their programs. Salient facilitators for those tested through their programs include support from staff in explaining the importance of testing and help in understanding and coping with test results. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF